Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson’s disease

A microsphere–gel in situ forming implant (MS–Gel ISFI) dual-controlled drug delivery system was applied to a high water-soluble small-molecule compound Rasagiline mesylate (RM) for effective treatment of Parkinson’s disease. This injectable complex depot system combined an in situ phase transition...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Deliv
Main Authors: Jiang, Ying, Zhang, Xuemei, Mu, Hongjie, Hua, Hongchen, Duan, Dongyu, Yan, Xiuju, Wang, Yiyun, Meng, Qingqing, Lu, Xiaoyan, Wang, Aiping, Liu, Wanhui, Li, Youxin, Sun, Kaoxiang
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058670/
https://ncbi.nlm.nih.gov/pubmed/29275639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2017.1419514
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados